Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain MESO message board posts where the ticker symbol MESO has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

Related news from
Thu, 20 Sep 2018
10:30:00 +0000
Children Treated With Remestemcel-L Continue to Have Strong Survival Outcomes at Six Months in Mesoblast’s Phase 3 Trial for Acute Graft Versus Host Disease
NEW YORK and MELBOURNE, Australia, Sept. 20, 2018-- Mesoblast Limited today announced continued strong survival outcomes through Day 180 in children with steroid refractory acute Graft Versus Host Disease ...
Mon, 17 Sep 2018
10:00:00 +0000
Tasly Pharmaceutical Group Receives All Necessary Approvals for Transaction With Mesoblast
Nasdaq: MESO) today announced that Tasly Pharmaceutical Group has successfully obtained all necessary approvals, including the Safe Administration of Foreign Exchange, required for closing the investment agreement and the development and collaboration agreement with Mesoblast to commercialize cell therapies for cardiovascular diseases in China. Tasly Pharmaceutical Group (SHA:600535) is one of the largest pharmaceutical companies in China with more than 20 years of operational history.
Thu, 30 Aug 2018
20:50:53 +0000
Mesoblast Limited (ASX:MSB) Is Expected To Breakeven
Mesoblast Limited’s (ASX:MSB): Mesoblast Limited develops cell-based medicines. With the latest financial year loss of -US$76.8m and a trailing-twelve month of -US$41.6m, the AU$750.5m market-cap alleviates its loss by movingRead More...
Wed, 29 Aug 2018
22:56:11 +0000
Mesoblast Reports Fourth Quarter and Full-Year 2018 Financial Results and Operational Highlights
MELBOURNE, Australia and NEW YORK, Aug. 29, 2018-- Mesoblast Limited today reported strong financial results and provided operational highlights for the fourth quarter and full-year ended June 30, 2018.. ...
Wed, 29 Aug 2018
11:43:07 +0000
Mesoblast's Earnings Outlook
Mesoblast (NASDAQ: MESO ) releases its next round of earnings Wednesday. Here's Benzinga's essential guide to Mesoblast's Q4 earnings report. Earnings and Revenue Analysts are predicting Mesoblast will ...
Wed, 29 Aug 2018
01:04:52 +0000
Mesoblast Provides Update on Transaction With Tasly Pharmaceutical Group
Nasdaq: MESO) today announced that Tasly Pharmaceutical Group has received People's Republic of China governmental approvals of Overseas Direct Investment from Tianjin Commission of Commerce and Tianjin Development and Reform Commission to enter into an investment agreement as well as a development and collaboration agreement with Mesoblast to commercialize cell therapies for cardiovascular diseases in China. Under the terms of the agreements with Tasly, on closing Mesoblast will receive US$40 million, comprising a US$20 million upfront technology access fee and US$20 million for equity in Mesoblast purchased by Tasly at AUD$1.86 per share.
Tue, 21 Aug 2018
11:30:00 +0000
Analysis: Positioning to Benefit within Alamos Gold, Nomad Foods, MyoKardia, Mesoblast, Core-Mark Holding, and Jounce Therapeutics — Research Highlights Growth, Revenue, and Consolidated Results
NEW YORK, Aug. 21, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Alamos ...
Tue, 17 Jul 2018
10:32:24 +0000
Mesoblast Enters Into Strategic Cardiovascular Alliance for China With Tasly Pharmaceutical Group
NEW YORK and MELBOURNE, Australia, July 17, 2018-- Mesoblast Limited today announced that it has entered into a strategic alliance with one of China’ s largest pharmaceutical companies, Tasly Pharmaceutical ...
Tue, 17 Jul 2018
10:17:18 +0000
BRIEF-Tasly Pharmaceutical To Invest $20 Million In Australia's Mesoblast Limited
July 17 (Reuters) - Tasly Pharmaceutical Group Co Ltd : * SAYS IT SIGNS AGREEMENT TO INVEST $20 MILLION IN AUSTRALIA'S MESOBLAST LIMITED Source text in Chinese: https://bit.ly/2L387MD Further company coverage: ...
Wed, 11 Jul 2018
10:00:00 +0000
Leading Commercial and Transactional Healthcare Executive Shawn Cline Tomasello Joins Mesoblast Board
Mesoblast Limited (MESO) (ASX:MSB) today announced that Shawn Cline Tomasello has joined its Board of Directors. With more than 30 years’ experience in the pharmaceutical and biotech industries, Ms Tomasello brings substantial commercial and transactional experience to the Mesoblast board. Since 2015, Ms Tomasello has been Chief Commercial Officer at leading immuno-oncology cell therapy company Kite Pharma, where she played a pivotal role in the company’s acquisition in 2017 by Gilead Sciences for $11.9 billion.
Mon, 02 Jul 2018
10:00:00 +0000
Mesoblast Enters Into US$50M Financing with Novaquest Capital for Commercial Readiness of Remestemcel-l in the Treatment of Acute Graft Versus Host Disease
Mesoblast Limited (MESO) (ASX:MSB) today announced a US$50 million financing from NovaQuest Capital Management, L.L.C. (NovaQuest) for the continued development and commercialization of its allogeneic product candidate remestemcel-L (MSC-100-IV) for children with steroid refractory acute Graft versus Host Disease (aGVHD). Mesoblast Chief Executive Dr Silviu Itescu stated: “We are pleased to have NovaQuest’s support for our plans to bring remestemcel-L to market. This transaction is underpinned by the strength of our GVHD Phase 3 clinical trial results.
Thu, 21 Jun 2018
13:28:00 +0000
Mesoblast Soars on Stem-Cell Treatment Data
The Australian company unveiled data from a study evaluating a potential treatment for children with steroid refractory acute Graft Versus Host Disease.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "It [ValueForum] has provided me with eye opening information on a wide scale. The collective wisdom of the membership is astounding and somewhat intimidating; but useful input is appreciated pretty universally." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards